Abbott Laboratories Income from Continuous Operations 2010-2024 | ABT
Abbott Laboratories income from continuous operations for the twelve months ending September 30, 2024 was $5.767B, a 11.72% increase year-over-year.
- Abbott Laboratories annual income from continuous operations for 2023 was $5.723B, a 17.45% decline from 2022.
- Abbott Laboratories annual income from continuous operations for 2022 was $6.933B, a 1.95% decline from 2021.
- Abbott Laboratories annual income from continuous operations for 2021 was $7.071B, a 58.15% increase from 2020.